IL2 and pericardial effusion: Other events accounting for the pathogenesis of cancer treatment-related pericardial effusion (CTR-pericardial effusion) are pericardial and endomyocardial fibrosis (busulfan) [21] and increased endothelial permeability (interleukin-2 and dasatinib) [22, 23].